000 01788 a2200505 4500
005 20250518100707.0
264 0 _c20210512
008 202105s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2020.127174
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSteeneck, Christoph
245 0 0 _aDiscovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_c06 2020
300 _a127174 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAmides
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Discovery
650 0 4 _aMicrosomes, Liver
_xchemistry
650 0 4 _aMolecular Structure
650 0 4 _aNuclear Receptor Subfamily 1, Group F, Member 3
_xagonists
650 0 4 _aOxadiazoles
_xadministration & dosage
650 0 4 _aRats
650 0 4 _aStructure-Activity Relationship
650 0 4 _aThiazoles
_xadministration & dosage
700 1 _aGege, Christian
700 1 _aKinzel, Olaf
700 1 _aAlbers, Michael
700 1 _aKleymann, Gerald
700 1 _aSchlüter, Thomas
700 1 _aSchulz, Andreas
700 1 _aXue, Xiaohua
700 1 _aCummings, Maxwell D
700 1 _aFourie, Anne M
700 1 _aLeonard, Kristi A
700 1 _aScott, Brian
700 1 _aEdwards, James P
700 1 _aHoffmann, Thomas
700 1 _aGoldberg, Steven D
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 30
_gno. 12
_gp. 127174
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2020.127174
_zAvailable from publisher's website
999 _c30901011
_d30901011